Inventor · disambiguated record
Todd C. Zion
Also filed as: ZION TODD C
50 granted patents·11 pending applications·411 citations·filing 1998–2025
98Inventor score
Top patents by PatentIndex Score
61 records- 0198US12454565B2PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of useAKSTON BIOSCIENCES CORP·Filed 2025·Granted Oct 28, 2025·1 cites·20 claims
- 0298US11192930B2Ultra-long acting insulin-Fc fusion protein and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Dec 7, 2021·5 cites·7 claims
- 0398US10961294B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Mar 30, 2021·24 cites·22 claims
- 0498US10947292B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Mar 16, 2021·23 cites·21 claims
- 0598US10870686B2Ultra-long acting insulin-FC fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Dec 22, 2020·23 cites·21 claims
- 0698US10851147B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Dec 1, 2020·23 cites·21 claims
- 0797US11673934B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jun 13, 2023·2 cites·20 claims
- 0897US11186623B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Nov 30, 2021·6 cites·20 claims
- 0996US11919935B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Mar 5, 2024·2 cites·14 claims
- 1096US11814418B2Ultra-long acting insulin-Fc fusion protein and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Nov 14, 2023·2 cites·14 claims
- 1196US11773151B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Oct 3, 2023·2 cites·15 claims
- 1296US11261229B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Mar 1, 2022·3 cites·14 claims
- 1395US11213581B2Antigen specific immunotherapy for COVID-19 fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jan 4, 2022·3 cites·27 claims
- 1495US10597435B2Insulin-Fc fusions and methods of useAKSTON BIOSCIENCES CORP·Filed 2019·Granted Mar 24, 2020·21 cites·17 claims
- 1594US11267862B2Ultra-long acting insulin-Fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2020·Granted Mar 8, 2022·3 cites·14 claims
- 1694US11198719B2Ultra-long acting insulin-Fc fusion protein and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Dec 14, 2021·2 cites·3 claims
- 1794US7531191B2Stimuli-responsive systems for controlled drug deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2003·Granted May 12, 2009·48 cites·49 claims
- 1892US8062668B2Stimuli-responsive systems for controlled drug deliveryYING JACKIE Y·Filed 2009·Granted Nov 22, 2011·8 cites·25 claims
- 1991US8569231B2Soluble non-depot insulin conjugates and uses thereofZION TODD C·Filed 2010·Granted Oct 29, 2013·7 cites·12 claims
- 2091US7687608B2Methods for reducing the mitogenicity of lectin compositionsSMARTCELLS INC·Filed 2006·Granted Mar 30, 2010·21 cites·11 claims
- 2190US9074015B2Recombinantly expressed insulin polypeptides and uses thereofLANCASTER THOMAS M·Filed 2011·Granted Jul 7, 2015·23 cites·7 claims
- 2290US8846103B2Exogenously triggered controlled release materials and uses thereofZION TODD C·Filed 2010·Granted Sep 30, 2014·7 cites·11 claims
- 2389US9050370B2Conjugate based systems for controlled drug deliveryZION TODD C·Filed 2010·Granted Jun 9, 2015·9 cites·18 claims
- 2489US8906850B2Crystalline insulin-conjugatesZION TODD C·Filed 2010·Granted Dec 9, 2014·12 cites·15 claims
- 2588US2024101635A1Ultra-long acting insulin-fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 2687US11359001B2Insulin-Fc fusions and methods of useAKSTON BIOSCIENCES CORP·Filed 2017·Granted Jun 14, 2022·7 cites·19 claims
- 2787US11352407B2Ultra-long acting insulin-Fc fusion proteinsAKSTON BIOSCIENCES CORP·Filed 2020·Granted Jun 7, 2022·1 cites·20 claims
- 2887US9114176B2Exogenously triggered controlled release materials and uses thereofSMARTCELLS INC·Filed 2014·Granted Aug 25, 2015·4 cites·13 claims
- 2986US8933207B2Drug-ligand conjugates, synthesis thereof, and intermediates theretoCHEN ZHIYU·Filed 2011·Granted Jan 13, 2015·19 cites·1 claims
- 3085US8623345B2Terminally-functionalized conjugates and uses thereofZION TODD C·Filed 2010·Granted Jan 7, 2014·4 cites·7 claims
- 3184US9463249B2Crystalline insulin-conjugatesSMARTCELLS INC·Filed 2014·Granted Oct 11, 2016·5 cites·13 claims
- 3282US8940690B2Synthetic conjugates and uses thereofZION TODD C·Filed 2010·Granted Jan 27, 2015·6 cites·18 claims
- 3381US9579391B2Conjugate based systems for controlled drug deliverySMARTCELLS INC·Filed 2015·Granted Feb 28, 2017·2 cites·22 claims
- 3481US2024182539A1Ultra-long acting insulin-fc fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2024·Application pending·0 cites
- 3580US8603529B2Polynucleotide aptamer-based cross-linked materials and uses thereofZION TODD C·Filed 2010·Granted Dec 10, 2013·5 cites·11 claims
- 3680US6482562B2Toner particles of controlled morphologyEASTMAN KODAK CO·Filed 2001·Granted Nov 19, 2002·20 cites·13 claims
- 3779US12240881B2Ultra-long acting insulin-Fc fusion protein and methods of useDECHRA LTD·Filed 2023·Granted Mar 4, 2025·0 cites·10 claims
- 3879US9265838B2Conjugate based systems for controlled drug deliverySMARTCELLS INC·Filed 2014·Granted Feb 23, 2016·2 cites·20 claims
- 3979US9068013B2Recombinant lectins, binding-site modified lectins and uses thereofLANCASTER THOMAS M·Filed 2011·Granted Jun 30, 2015·7 cites·17 claims
- 4079US8357400B2Stimuli-responsive systems for controlled drug deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2011·Granted Jan 22, 2013·1 cites·20 claims
- 4178US12343393B2Antigen specific immunotherapy for COVID-19 fusion proteins and methods of useVAKSTON INC·Filed 2023·Granted Jul 1, 2025·0 cites·20 claims
- 4278US10398781B2Conjugate based systems for controlled drug deliverySMARTCELLS INC·Filed 2017·Granted Sep 3, 2019·1 cites·20 claims
- 4376US11707517B2Antigen specific immunotherapy for COVID-19 fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jul 25, 2023·0 cites·16 claims
- 4476US6380297B1Polymer particles of controlled shapeNEXPRESS SOLUTIONS LLC·Filed 1999·Granted Apr 30, 2002·35 cites·21 claims
- 4574US8729242B2Methods for reducing the mitogenicity of lectin compositionsLANCASTER THOMAS M·Filed 2010·Granted May 20, 2014·1 cites·24 claims
- 4674US2025289863A1Ultra-long acting insulin-fc fusion proteins and methods of useDECHRA LTD·Filed 2025·Application pending·0 cites
- 4773US2023272031A1Insulin-fc fusion proteins and methods of use to treat cancerAKSTON BIOSCIENCES CORP·Filed 2023·Application pending·0 cites
- 4872US12195511B2Ultra-long acting insulin-Fc fusion proteinAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jan 14, 2025·0 cites·24 claims
- 4972US8697643B2Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicatorLANCASTER THOMAS M·Filed 2012·Granted Apr 15, 2014·1 cites·17 claims
- 5071US11667689B2Insulin-Fc fusion proteins and methods of use to treat cancerAKSTON BIOSCIENCES CORP·Filed 2022·Granted Jun 6, 2023·0 cites·13 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Todd C. Zion files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →